Catherine Knupp - ZOETIS A President

ZOE Stock  EUR 167.50  0.48  0.29%   

President

Dr. Catherine A. Knupp is Executive Vice President, President Research and Development of Zoetis Inc. Dr. Knupp has served as our Executive Vice President and President of Research and Development since October 2012. From 2005 to 2012, she served as Vice President of Pfizers Veterinary Medicine Research and Development business unit. Dr. Knupp joined Pfizer in July 2001 and held various positions, including Vice President of Pfizers Michigan laboratories for Pharmacokinetics, Dynamics and Metabolism. since 2012.
Age 58
Tenure 12 years
Professional MarksPh.D
Knupp earned her Doctor of Veterinary Medicine degree in 1985 from the University of Illinois, where she also received a master degree in toxicology and a bachelor degree in veterinary biosciences. She also earned another bachelor degree in chemistry from Western Illinois University.

Similar Executives

Found 1 records

PRESIDENT Age

Mark DuffPerma Fix Environmental Service
60
ZOETIS A (ZOE) is traded on Munich Exchange in Germany and employs 26 people.

ZOETIS A Leadership Team

Elected by the shareholders, the ZOETIS A's board of directors comprises two types of representatives: ZOETIS A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ZOETIS. The board's role is to monitor ZOETIS A's management team and ensure that shareholders' interests are well served. ZOETIS A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ZOETIS A's outside directors are responsible for providing unbiased perspectives on the board's policies.
Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
William Steere, Independent Director
Roxanne Lagano, Chief Human Resource Officer, Executive Vice President and Global Operations
Willie Reed, Independent Director
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Glenn David, Chief Financial Officer, Executive Vice President
Sanjay Khosla, Independent Director
Catherine Knupp, Executive Vice President and Presidentident - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Paul Bisaro, Independent Director
Antoinette Leatherberry, Director

ZOETIS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ZOETIS A a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ZOETIS Stock Analysis

When running ZOETIS A's price analysis, check to measure ZOETIS A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZOETIS A is operating at the current time. Most of ZOETIS A's value examination focuses on studying past and present price action to predict the probability of ZOETIS A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZOETIS A's price. Additionally, you may evaluate how the addition of ZOETIS A to your portfolios can decrease your overall portfolio volatility.